BioCryst Pharmaceuticals, Inc. BCRX

Updated: 17 Jun 2026

NASDAQ | Biotech | Rare diseases and antiviral medicines

No signal published yet

We already track BioCryst Pharmaceuticals and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow BioCryst Pharmaceuticals free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Rare diseases and antiviral medicines
We're already tracking BioCryst Pharmaceuticals, Inc. — here are the latest events we've registered

Recent News

  • In June 2026, BioCryst presented new clinical data and real-world evidence for its HAE portfolio at the EAACI Annual Meeting. The company also recently entered into a licensing agreement with Neopharmed Gentili for navenibart in Europe, receiving a $70 million upfront payment in May 2026.

What Firelda Watch includes for BioCryst Pharmaceuticals, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of BioCryst Pharmaceuticals, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Black Mammoth Metals Corp
BMM
NEUTRAL
Crustal Resources B
HOLD
Crustal Minerals
CRUST B
NEUTRAL
Bioarctic
BIOA B
BUY
Recipharm
RECI B
NEUTRAL

Biotech

More companies in this sector

Want to follow BioCryst Pharmaceuticals, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow BioCryst Pharmaceuticals free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

BioCryst Pharmaceuticals, Inc. BCRX
BioCryst Pharmaceuticals — follow and we'll monitor it
Follow BioCryst Pharmaceuticals free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.